4//SEC Filing
Strem Brian M. 4
Accession 0001104659-21-142537
CIK 0001372514other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:35 PM ET
Size
7.0 KB
Accession
0001104659-21-142537
Insider Transaction Report
Form 4
Strem Brian M.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2021-11-18$1.41/sh+17,853$25,173→ 27,370 total - Award
Common Stock
2021-10-21+9,517→ 9,517 total
Footnotes (2)
- [F1]Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.41, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001876429
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:35 PM ET
- Size
- 7.0 KB